Acro Biomedical (ACBM) Gross Profit (2017 - 2022)

Acro Biomedical has reported Gross Profit for 6 years, with the latest figure at $64000.0 in Q4 2022.

• On a quarterly basis, Gross Profit fell 57.33% year-over-year to $64000.0 in Q4 2022; TTM through Sep 2023 was $64000.0, a 71.74% decrease from a year earlier, with the FY2022 full-year figure at $140500.0, down 45.86% from the prior year.
• Gross Profit was $64000.0 for Q4 2022 at Acro Biomedical, down from $76500.0 in the prior quarter.
• The five-year high for Gross Profit was $252600.0 in Q3 2018, with the low at $12096.0 in Q4 2019.
• Average Gross Profit over 5 years is $126890.9, with a median of $135400.0 recorded in 2018.
• The sharpest annual moves came in 2019 and 2022: Gross Profit tumbled 91.07% in 2019, then surged 159.32% in 2022.
• Over 5 years, Gross Profit stood at $135400.0 in 2018, then sank by 91.07% to $12096.0 in 2019, then surged by 1217.82% to $159404.0 in 2020, then retreated by 5.9% to $150000.0 in 2021, then plunged by 57.33% to $64000.0 in 2022.
• The last three Gross Profit figures came in at $64000.0 (Q4 2022), $76500.0 (Q1 2022), and $150000.0 (Q4 2021), per Business Quant data.